Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors.

{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:38617302", "kind": "science-record", "revision": 4, "content_hash": "sha256:bc4f2aa5d5e8582b5f3d74bbe356d0a7453a7935db6196c5f35718a37d6c13d7", "created_at": "2026-11-01T19:20:35Z", "updated_at": "2026-11-01T22:11:41Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors.", "doi": "10.1101/2024.04.02.587656", "pmid": "38617302", "authors": ["Arba Karcini", "Nicole R Mercier", "Iulia M Lazar"], "journal": "bioRxiv : the preprint server for biology", "year": 2024, "abstract": "Modern cancer treatment approaches aim at achieving cancer remission by using targeted and personalized therapies, as well as harnessing the power of the immune system to recognize and eliminate the cancer cells. To overcome a relatively short-lived response due to the development of resistance to the administered drugs, combination therapies have been pursued, as well. To expand the outlook of combination therapies, the objective of this study was to use high-throughput data generation technologies such as mass spectrometry and proteomics to investigate the response of HER2+ breast cancer cells to a mixture of two kinase inhibitors that has not been adopted yet as a standard treatment regime. The broader landscape of biological processes that are affected by inhibiting two major pathways that sustain the growth and survival of cancer cells, i.e., EGFR and PI3K/AKT, was investigated by treating SKBR3/HER2+ breast cancer cells with Lapatinib or a mixture of Lapatinib/Ipatasertib small molecule drugs. Changes in protein expression and/or activity in response to the drug treatments were assessed by using two complementary quantitative proteomic approaches based on peak area and peptide spectrum match measurements. Over 900 proteins matched by three unique peptide sequences (FDR<0.05) were affected by the exposure of cells to the drugs. The work corroborated the anti-proliferative activity of Lapatinib and Ipatasertib, and, in addition to cell cycle and growth arrest processes enabled the identification of several multi-functional proteins with roles in cancer-supportive hallmark processes. Among these, immune response, adhesion and migration emerged as particularly relevant to the ability to effectively suppress the proliferation and dissemination of cancer cells. The supplementation of Lapatinib with Ipatasertib further affected the expression or activity of additional transcription factors and proteins involved in gene expression, trafficking, DNA repair, and development of multidrug resistance. Furthermore, over fifty of the affected proteins represented approved or investigational targets in the DrugBank database, which through their protein-protein interaction networks can inform the selection of effective therapeutic partners. Altogether, our findings exposed a broad plethora of yet untapped opportunities that can be further explored for enhancing the anti-cancer effects of each drug as well as of many other multi-drug therapies that target the EGFR/ERBB2 and PI3K/AKT pathways. The data are available via ProteomeXchange with identifier PXD051094.", "claims": [{"id": "claim-method", "statement": "Differentially expressed proteins were selected by calculating the Log2 values of the spectral count ratios of the two datasets and using a two-tailed unpaired t-test for assessing significance.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38617302", "locator": "sections[11] \"Spectral counting-based quantitation.\" paragraph 2", "quote": "Differentially expressed proteins were selected by calculating the Log2 values of the spectral count ratios of the two datasets and using a two-tailed unpaired t-test for assessing significance."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The mass spectrometry raw files were deposited to the ProteomeXchange Consortium via the PRIDE [106] partner repository with the dataset identifier: PXD051094.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38617302", "locator": "sections[30] \"Data availability.\" paragraph 2", "quote": "The mass spectrometry raw files were deposited to the ProteomeXchange Consortium via the PRIDE [106] partner repository with the dataset identifier: PXD051094."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Over 900 proteins matched by three unique peptide sequences (FDR<0.05) were affected by the exposure of cells to the drugs.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:38617302", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Over 900 proteins matched by three unique peptide sequences (FDR<0.05) were affected by the exposure of cells to the drugs."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "Over 900 proteins matched by three unique peptide sequences (FDR<0.05) were affected by the exposure of cells to the drugs.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:38617302"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD051094"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD051094"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:38617302", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1101/2024.04.02.587656", "sha256": "sha256:09d3cea82b65880ce121040364748663d2191b138ef09a79944ae7a2fd5af167", "bytes": 62097, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1101/2024.04.02.587656", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC11014527", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD051094", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD051094", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD051094", "version": null, "note": "The mass spectrometry raw files were deposited to the ProteomeXchange Consortium via the PRIDE [106] partner repository with the dataset identifier: PXD051094.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The mass spectrometry raw files were deposited to the ProteomeXchange Consortium via the PRIDE [106] partner repository with the dataset identifier: PXD051094.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Ipatasertib Kinase Inhibitors", "resolution_checked_at": "2026-11-01T20:16:17Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:PXD051094 not downloaded", "asset:data:geo:PXD051094 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "network_analysis", "specific": "ppi_network", "label": "Network / pathway analysis", "dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "protein-protein interaction"}}, {"id": "method-2", "family": null, "specific": null, "label": "Two-tailed unpaired t-test for spectral-count-based differential expression, t-test for peak-area-based differential expression, and Benjamini-Hochberg correction for multiple testing.", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Differentially expressed proteins were selected by calculating the Log2 values of the spectral count ratios of the two datasets and using a two-tailed unpaired t-test for assessing significance."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: ppi_network."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD051094"], "resolved_accessions": ["PXD051094"], "statements": ["The mass spectrometry raw files were deposited to the ProteomeXchange Consortium via the PRIDE [106] partner repository with the dataset identifier: PXD051094."], "basis": "The paper names PXD051094 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "assets": ["source:pmid:38617302", "data:geo:PXD051094"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD051094"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:15:29Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 15548, "completion_tokens": 800, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:38617302", "type": "paper", "label": "pmid:38617302"}, {"id": "source:pmid:38617302", "type": "manuscript", "label": "PMID 38617302 full text"}, {"id": "data:geo:PXD051094", "type": "dataset", "label": "GEO PXD051094"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:38617302", "type": "paper", "label": "pmid:38617302"}, {"id": "source:pmid:38617302", "type": "manuscript", "label": "PMID 38617302 full text"}, {"id": "data:geo:PXD051094", "type": "dataset", "label": "GEO PXD051094"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-38617302", "type": "extraction", "used": ["source:pmid:38617302"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD051094", "type": "accession_resolution", "used": ["data:geo:PXD051094"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:38617302", "parent_hash": "sha256:b6a77ecb19f1b32be7d7052637b8abd0d3cc0e30fd68bce75fe974cc85f6802e", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:PXD051094 licence not read", "asset:data:geo:PXD051094 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cell", "n technologies such as mass spectrometry and proteomics to investigate the response of HER2+ breast", "ssed by using two complementary quantitative proteomic approaches based on peak area and peptide sp", "oughput data generation technologies such as mass spectrometry and proteomics to investigate the response o"], "order_basis": "paper_text_order:0", "id": "assay:1"}, {"role": "data_generation", "definition_id": "western_blot", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["asertib were from Selleck (Houston, TX). For Western blotting, the antibodies were purchased from Cell Sig"], "order_basis": "paper_text_order:3706", "id": "assay:2"}, {"role": "analysis", "definition_id": "network_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["protein-protein interaction"], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}